Literature DB >> 12607712

Increased susceptibility of hypertrophied hearts to ischemic injury.

Ingeborg Friehs1, Pedro J del Nido.   

Abstract

Cardiac hypertrophy is an adaptive response that compensates for increased workload by normalizing wall stress and preserving cardiac contractile function. In advanced stages, however, clinical and experimental studies have shown that when the high workload is maintained, hypertrophy progresses to ventricular dilatation, contractile dysfunction, and decreased tolerance to ischemia/reperfusion. Development of hypertrophy is accompanied by distinct qualitative and quantitative changes in contractile protein expression and isoform switching, cytosolic calcium regulation, and substrate delivery and use. We have focused our investigations on changes in substrate delivery and capillary density in pressure overload hypertrophy and on the effects that these changes have on tolerance to ischemia/reperfusion. This report summarizes our work in this area using a model of aortic banding in 10-day-old rabbits, which exhibits the same pattern of concentric hypertrophy early, followed by ventricular dilatation and contractile dysfunction that is clinically apparent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607712     DOI: 10.1016/s0003-4975(02)04692-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress.

Authors:  T Ravingerová; I Bernátová; J Matejíková; V Ledvényiová; M Nemčeková; O Pecháňová; N Tribulová; J Slezák
Journal:  Exp Clin Cardiol       Date:  2011

2.  Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium.

Authors:  Hui Zhang; Xiuzhen Huang; Kuo Liu; Juan Tang; Lingjuan He; Wenjuan Pu; Qiaozhen Liu; Yan Li; Xueying Tian; Yue Wang; Libo Zhang; Ying Yu; Hongyan Wang; Ronggui Hu; Fengchao Wang; Ting Chen; Qing-Dong Wang; Zengyong Qiao; Li Zhang; Kathy O Lui; Bin Zhou
Journal:  Cell Res       Date:  2017-08-15       Impact factor: 25.617

3.  An animal model of endocardial fibroelastosis.

Authors:  Ingeborg Friehs; Ben Illigens; Ivan Melnychenko; Tachi Zhong-Hu; Elisabeth Zeisberg; Pedro J Del Nido
Journal:  J Surg Res       Date:  2012-08-17       Impact factor: 2.192

4.  Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury.

Authors:  Ingeborg Friehs; Hung Cao-Danh; Meena Nathan; Francis X McGowan; Pedro J del Nido
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

5.  Mitochondrial BKCa channels contribute to protection of cardiomyocytes isolated from chronically hypoxic rats.

Authors:  Gudrun H Borchert; Chengtao Yang; Frantisek Kolár
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

6.  Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure.

Authors:  A E Loot; A J M Roks; D Westermann; H-D Orzechowski; C Tschöpe; J C Wilschut; R A Tio; W H van Gilst; R H Henning
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

Review 7.  Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

Authors:  Moritz Osterholt; T Dung Nguyen; Michael Schwarzer; Torsten Doenst
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 8.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.

Authors:  Rodrigo Barillas; Ingeborg Friehs; Hung Cao-Danh; Joseph F Martinez; Pedro J del Nido
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

10.  Myocardial hypertrophy overrides the angiogenic response to hypoxia.

Authors:  Yeong-Hoon Choi; Douglas B Cowan; Meena Nathan; Dimitrios Poutias; Christof Stamm; Pedro J del Nido; Francis X McGowan
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.